Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Option Care Health ( (OPCH) ) has issued an update.
At the 2025 Annual Meeting of Stockholders held on May 14, 2025, Option Care Health‘s Board of Directors approved amendments to the company’s Certificate of Incorporation and Bylaws. These changes include allowing stockholders to request special meetings, limiting monetary liability for certain officers, and removing outdated provisions related to HC Group. The stockholders also elected directors, ratified KPMG LLP as the accounting firm, and approved executive compensation, reflecting a strategic shift to enhance governance and shareholder rights.
The most recent analyst rating on (OPCH) stock is a Buy with a $33.00 price target. To see the full list of analyst forecasts on Option Care Health stock, see the OPCH Stock Forecast page.
Spark’s Take on OPCH Stock
According to Spark, TipRanks’ AI Analyst, OPCH is a Outperform.
Option Care Health’s stock is bolstered by strong financial performance and positive earnings call insights, which include impressive revenue and EBITDA growth and strategic expansions. While technical indicators are neutral, the valuation appears reasonable for the sector. Despite some economic uncertainties, the company’s strategic initiatives and solid financial position provide a stable outlook.
To see Spark’s full report on OPCH stock, click here.
More about Option Care Health
Option Care Health, Inc. operates in the healthcare industry, focusing on providing home and alternate site infusion services. The company offers a range of infusion therapies and services, catering to patients with complex medical conditions.
Average Trading Volume: 2,212,183
Technical Sentiment Signal: Buy
Current Market Cap: $5.21B
For detailed information about OPCH stock, go to TipRanks’ Stock Analysis page.